Loading people...
Nadiya Ishnazarova currently serves as the Senior Director of Venture Investments at J&J Innovation – JJDC, Inc., the strategic venture capital arm of Johnson and Johnson. In this corporate venture capacity, she is responsible for sourcing, evaluating, and executing early-stage equity investments across the broader life sciences, biotechnology, and health innovation sectors. Prior to joining the investment team at JJDC, she worked as a Principal within a specialized biotechnology group, where she directed capital toward emerging therapeutic platforms and clinical-stage assets. Ishnazarova completed her formal scientific training by earning a PhD in Biochemistry from the University of Oxford, conducting specialized academic research focused on the complex molecular mechanisms of recombination-dependent replication. Her career trajectory represents a synthesis of rigorous academic research and institutional venture capital, maintaining a primary focus on advancing early-stage biotechnology enterprises toward commercialization.
